Orris

epidemiology of tetanus

Reading File
Finding Sources
Searching PubMed

tetanus epidemiology incidence global

Searching the Web

tetanus global epidemiology incidence 2024 WHO statistics

Finding Sources
Reading Web Page

https://ourworldindata.org/tetanus

Reading File
Reading File
Reading File
Reading File
Finding Sources
Loading Image
Searching Images

tetanus global distribution neonatal tetanus epidemiology map

Geospatial epidemiology visualization of leprosy prevalence at a global scale. This global choropleth map uses 2016 data from the World Health Organization and related health authorities to depict registered leprosy cases per 10,000 population. High-prevalence clusters appear in the Indian subcontinent, parts of Brazil and Indonesia, with substantial tropical distribution extending into other endemic regions; several African countries show lower to moderate rates or data limitations. The color ramp typically ranges from light tones in low-prevalence areas to deep red in countries with the highest reported burden, enabling rapid visual assessment of endemic regions. The map integrates standard geographic boundaries and presents a snapshot suitable for public health surveillance, travel medicine risk assessment, epidemiology education, and resource planning for diagnosis, treatment, and prevention programs. Limitations include reporting bias, variation in case definitions, and differences in surveillance capacity across countries; thus, prevalence per 10,000 is influenced by case finding and health system coverage. This visualization supports hypothesis generation about transmission dynamics, regional health priorities, and the impact of leprosy control initiatives over time. It can be used in academic settings, policy discussions, and clinical education to contextualize individual patient presentations within population-level risk landscapes.

Geospatial epidemiology visualization of leprosy prevalence at a global scale. This global choropleth map uses 2016 data from the World Health Organization and related health authorities to depict registered leprosy cases per 10,000 population. High-prevalence clusters appear in the Indian subcontinent, parts of Brazil and Indonesia, with substantial tropical distribution extending into other endemic regions; several African countries show lower to moderate rates or data limitations. The color ramp typically ranges from light tones in low-prevalence areas to deep red in countries with the highest reported burden, enabling rapid visual assessment of endemic regions. The map integrates standard geographic boundaries and presents a snapshot suitable for public health surveillance, travel medicine risk assessment, epidemiology education, and resource planning for diagnosis, treatment, and prevention programs. Limitations include reporting bias, variation in case definitions, and differences in surveillance capacity across countries; thus, prevalence per 10,000 is influenced by case finding and health system coverage. This visualization supports hypothesis generation about transmission dynamics, regional health priorities, and the impact of leprosy control initiatives over time. It can be used in academic settings, policy discussions, and clinical education to contextualize individual patient presentations within population-level risk landscapes.

Educational composite illustrating the global epidemiology and clinical pathology of Angiostrongylus cantonensis, the primary cause of eosinophilic meningitis in humans. Panel (a) is a global distribution map highlighting regions endemic to the parasite. Green-shaded areas (including parts of North America, South America, and East Asia) indicate confirmed presence with available cox1 genetic sequences, while red-shaded areas (sections of South America, Africa, South Asia, and Australia) indicate presence without cox1 genetic confirmation. Black stars mark specific study collection sites: Hawaii (HAW.1), Fatu Hiva (FH.1), Tenerife (TEN.1), and Sydney (SYD.1). Panel (b) is a high-magnification clinical photograph of a dissected pulmonary artery from a Polynesian rat (Rattus exulans), a definitive host. It demonstrates multiple adult female worms within the vascular lumen. The worms exhibit a characteristic 'barber-pole' appearance due to the intertwining of the dark intestine and white uterine tubes. A 2 mm scale bar is provided for morphological reference. The image is designed for parasitology and infectious disease education regarding zoonotic foodborne nematodiasis.

Educational composite illustrating the global epidemiology and clinical pathology of Angiostrongylus cantonensis, the primary cause of eosinophilic meningitis in humans. Panel (a) is a global distribution map highlighting regions endemic to the parasite. Green-shaded areas (including parts of North America, South America, and East Asia) indicate confirmed presence with available cox1 genetic sequences, while red-shaded areas (sections of South America, Africa, South Asia, and Australia) indicate presence without cox1 genetic confirmation. Black stars mark specific study collection sites: Hawaii (HAW.1), Fatu Hiva (FH.1), Tenerife (TEN.1), and Sydney (SYD.1). Panel (b) is a high-magnification clinical photograph of a dissected pulmonary artery from a Polynesian rat (Rattus exulans), a definitive host. It demonstrates multiple adult female worms within the vascular lumen. The worms exhibit a characteristic 'barber-pole' appearance due to the intertwining of the dark intestine and white uterine tubes. A 2 mm scale bar is provided for morphological reference. The image is designed for parasitology and infectious disease education regarding zoonotic foodborne nematodiasis.

This infographic is a world cartogram illustrating the global distribution of human poverty according to the United Nations Development Programme (UNDP). In this visualization, the land area of each territory is distorted to be proportional to its share of the global poverty index rather than its true geographic size. This clinical epidemiology tool uses a heat transfer algorithm to represent the density of the variable. Visually, the map shows a massive expansion of the African continent (shaded in red and pink) and South Asia (including India, Pakistan, and Bangladesh, shaded in yellow and orange), indicating a high prevalence of poverty-related health risks. Conversely, North America and Europe (shaded in blue and purple) are significantly diminished, appearing as thin slivers, which reflects their lower proportion of the global poverty index. This representation is used in public health education to demonstrate the correlation between socioeconomic status and health outcomes, such as mortality from preventable nutritional deficiencies and communicable diseases.

This infographic is a world cartogram illustrating the global distribution of human poverty according to the United Nations Development Programme (UNDP). In this visualization, the land area of each territory is distorted to be proportional to its share of the global poverty index rather than its true geographic size. This clinical epidemiology tool uses a heat transfer algorithm to represent the density of the variable. Visually, the map shows a massive expansion of the African continent (shaded in red and pink) and South Asia (including India, Pakistan, and Bangladesh, shaded in yellow and orange), indicating a high prevalence of poverty-related health risks. Conversely, North America and Europe (shaded in blue and purple) are significantly diminished, appearing as thin slivers, which reflects their lower proportion of the global poverty index. This representation is used in public health education to demonstrate the correlation between socioeconomic status and health outcomes, such as mortality from preventable nutritional deficiencies and communicable diseases.

I now have comprehensive information from multiple authoritative sources. Let me compose a thorough answer.

Epidemiology of Tetanus

1. Causative Agent and Reservoir

Tetanus is caused by the neurotoxin (tetanospasmin) of Clostridium tetani, a gram-positive, anaerobic, spore-forming bacillus. Its spores are found in up to 25% of soil samples, especially where animal manure has been applied. The organism also persists in the feces of domestic animals, farm animals, and poultry - and in about 10% of humans who carry it asymptotically in the colon. Because spores persist indefinitely in the environment, tetanus cannot be eradicated (unlike polio or smallpox) - only controlled through sustained vaccination.
  • Goldman-Cecil Medicine, p. 1334

2. Global Burden

Overall magnitude

MetricValue
WHO reported cases (2018)~15,100
WHO reported cases (2023)~16,300
WHO reported cases (2024)~17,670
Estimated unreported casesTens of thousands annually
Annual deaths (current estimate)~50,000 globally
Neonatal deaths (WHO estimate)~34,000 annually
Despite these numbers, the burden has fallen dramatically. In the 1980s, over 100,000 cases were reported per year; by 2018 this was ~15,000. In the 1990s, hundreds of thousands died annually; by the 2010s this fell to around 50,000/year. The chart below (from Rosen's Emergency Medicine) shows this trend alongside rising DTP3 vaccination coverage:
Global tetanus cases and DTP3 coverage 1980-2018, and US incidence 1900-2015
Panel A: Global reported cases (bars) fall as DTP3 coverage (lines) rises. Panel B: US incidence and death rates per 100,000 from 1900 to 2015.
  • Rosen's Emergency Medicine, p. 2589

3. Geographic Distribution

Tetanus is endemic worldwide but heavily concentrated in:
  • Sub-Saharan Africa and South Asia - these two regions account for the majority of global cases and deaths
  • South Asia's burden has fallen massively (from ~400,000 infections in 1990 to ~30,000 in 2019), but it remains the highest-burden region
  • Disease is more common in warm, damp climates and highly cultivated rural areas of developing countries
  • Cold regions have relatively low rates
  • Countries with low immunization coverage and poor sanitation carry the greatest burden
In high-income countries (e.g., US, EU): rates are extremely low. In the US, incidence fell from ~4 cases/million in the 1940s to <0.01/million by 2010. The EU reported ~92.8% DTP3 coverage in 2023 (ECDC).

4. Neonatal Tetanus (Tetanus Neonatorum)

Neonatal tetanus (MNT - Maternal and Neonatal Tetanus) deserves special attention:
  • An estimated 60,000 neonatal cases occur annually in low-income countries (Goldman-Cecil) with ~34,000 deaths (WHO/Rosen's estimate)
  • Caused by contamination of the umbilical cord during unclean delivery (using non-sterile instruments, applying contaminated substances to the cord stump)
  • Most affected infants are 6-9 days old at presentation - with a history of continuous crying, then cessation of sucking, followed by convulsions
  • Case fatality rates are extremely high in resource-poor settings
  • Prevention: maternal immunization with tetanus toxoid, clean delivery practices, and proper cord care
  • Creasy & Resnik's Maternal-Fetal Medicine, p. 4132-4136

5. Risk Factors and Portals of Entry

Wound types (most common portals of entry):
  • Puncture wounds (e.g., nail injuries, needle sticks)
  • Lacerations and abrasions
  • Contaminated soil wounds
  • Chronic skin ulcers, pressure sores
  • Burns
Patient-level risk factors:
  • Inadequate primary immunization (the dominant risk factor)
  • Waning immunity (especially in adults >65 years)
  • Intravenous drug use (accounts for ~50% of US cases)
  • Diabetes mellitus
  • Immunosuppression
  • Obstetric/postabortal tetanus (uterine trauma, especially in developing countries)
  • Postoperative tetanus after intestinal procedures
  • Foreign bodies, otitis media, corneal abrasions, dental procedures
Notably, no apparent wound source is found in a minority of cases, and some cases arise from trivial injuries. About 70% have a clear history of injury.
  • Rosen's Emergency Medicine, p. 2589

6. Age Distribution

  • In developing countries, neonates bear the highest burden (tetanus neonatorum)
  • In the US and other high-income countries, cases have shifted to older adults: those >65 years have the highest incidence (0.23 cases/million population) due to waning vaccine immunity
  • Cases also concentrate in injection drug users (50% of US cases)
  • Children vaccinated under national programs are well protected, but unvaccinated or incompletely vaccinated adults remain vulnerable

7. Case Fatality Rate (CFR)

GroupCFR
Overall (US)~18%
Age >70 years (US)Approaches 50%
Obstetric tetanusOften >50%
Neonatal tetanus (low-income settings)Very high (majority die without ICU care)
Respiratory complications (laryngospasm, ventilatory failure) and autonomic instability are the leading causes of death.

8. Transmission

  • Not person-to-person - tetanus is NOT transmitted between humans
  • Infection results from contamination of wounds with C. tetani spores from the environment (soil, feces, dust)
  • Entry requires a wound site with low oxygen tension (devitalized tissue, deep punctures, necrotic areas)
  • This explains why tetanus cannot be eradicated - the reservoir is environmental, not human

9. Impact of Vaccination

Tetanus toxoid is among the most effective vaccines ever developed. The epidemiologic impact is dramatic:
  • Global DTP3 coverage rose from <25% in 1980 to ~88% by 2018, with a corresponding steep fall in cases
  • In the US, cases fell from ~600/year pre-vaccine era to ~30/year currently
  • MNT elimination (defined as <1 case/1,000 live births per district) has been achieved in many countries through maternal immunization campaigns
  • EU/EEA DTP3 coverage averaged 92.8% in 2023 (range: Romania 79% to Luxembourg/Portugal/Hungary 99%)
A key epidemiologic challenge is that immunity is not lifelong - booster doses (Td) are needed every 10 years in adults, but compliance is poor, particularly among the elderly.
Summary: Tetanus remains a global public health problem, causing ~50,000 deaths/year, concentrated in neonates and unvaccinated populations in Sub-Saharan Africa and South Asia. In high-income countries it is rare but clusters among the elderly and intravenous drug users. The environmental reservoir ensures it cannot be eradicated; the only control strategy is sustained immunization.

epidemiology of tetanus

Reading File
Finding Sources
Searching PubMed

tetanus epidemiology incidence global

Searching the Web

tetanus global epidemiology WHO 2024 2025 incidence deaths statistics

Reading File
Reading File
Reading File
Reading File
Loading Image
Reading Web Page

https://www.thelancet.com/journals/lancet/article/PIIS0140-6…

I now have comprehensive data from four major textbooks and current web sources. Here is the full epidemiology of tetanus:

Epidemiology of Tetanus

Agent and Environmental Reservoir

Tetanus is caused by the neurotoxin (tetanospasmin) of Clostridium tetani - a gram-positive, anaerobic, spore-forming bacillus. Its spores are ubiquitous in the environment:
  • Found in up to 25% of soil samples, especially where animal manure has been applied
  • Present in feces of domestic and farm animals, poultry
  • Carried asymptomatically in the colon of ~10% of humans
  • Spores survive indefinitely in the environment
This is why tetanus cannot be eradicated - only controlled through sustained vaccination. Even if cases dropped to zero, the environmental reservoir ensures unvaccinated people remain at risk permanently.
  • Goldman-Cecil Medicine, p. 1332

Global Burden

Global tetanus reported cases and DTP3 vaccination coverage 1980-2018, and US incidence/mortality 1900-2015
Panel A: Global reported tetanus cases (bars) fall inversely with rising DTP3 coverage. Panel B: Dramatic decline in US incidence and deaths per 100,000 since 1900. (Rosen's Emergency Medicine, Fig. 118.3)
MetricFigures
WHO reported cases (2018)~15,100
WHO reported cases (2023)~16,300
WHO reported cases (2024)~17,670
Estimated annual global deaths30,000-50,000
Estimated annual neonatal deaths~34,000
Estimated neonatal cases in LMICs~60,000/year
In the 1980s, over 100,000 cases/year were reported globally; this has fallen by ~85% thanks to vaccination. Deaths in the 1990s numbered in the hundreds of thousands annually; by the 2010s this was ~50,000/year. A 2025 Lancet review confirms the current estimate of 30,000-50,000 annual deaths.
  • Rosen's Emergency Medicine, p. 2589
  • Goldman-Cecil Medicine, p. 1334

Geographic Distribution

Tetanus is endemic worldwide but the burden is steeply concentrated:
  • Sub-Saharan Africa and South Asia account for the majority of global cases and deaths
  • South Asia: incidence fell from ~400,000 new infections in 1990 to ~30,000 in 2019 - still the highest-burden region
  • Disease is most common in warm, damp climates and highly cultivated rural areas of developing nations
  • Cold regions have low rates
  • High-income countries (US, EU) have near-eliminated the disease through routine immunization
  • Rosen's Emergency Medicine, p. 2589; Our World in Data - Tetanus

Epidemiology in High-Income Countries

United States:
  • Pre-vaccine era (1940s): ~4 cases/million population
  • By 2010: <0.01 cases/million population
  • Currently: ~20-30 reported cases/year
  • US mortality among 2009-2017 cases: 7% overall
  • Adult vaccination coverage (18-64 yrs): only 63%; adults ≥65 yrs: only 61% (CDC data)
European Union (ECDC, 2023):
  • Average DTP3 coverage: 92.8% (range: Romania 79% - Luxembourg/Portugal/Hungary 99%)
  • Campbell's Operative Orthopaedics 15th Ed, p. 3279-3284; Rosen's Emergency Medicine, p. 2589

Neonatal Tetanus (Tetanus Neonatorum)

Neonatal tetanus is the most devastating form epidemiologically, causing the majority of tetanus deaths globally:
  • Results from umbilical cord contamination during unclean deliveries (non-sterile instruments, application of contaminated substances to cord stump)
  • Most affected neonates present at 6-9 days of age with a history of continuous crying for up to 48 hours, then cessation of sucking, convulsions, and fever
  • Clinical features are more severe than in adults: prominent dysphagia, respiratory complications, high fever, rapid fulminating course
  • Case fatality is very high in resource-poor settings without ICU access
  • Maternal tetanus (post-delivery or abortion): CFR often exceeds 50%
Prevention strategies: maternal immunization with tetanus toxoid during pregnancy, clean delivery practices, proper cord care with disinfectants.
  • Creasy & Resnik's Maternal-Fetal Medicine, p. 4132-4136

Risk Factors and Portals of Entry

Host-level risk factors:
  • Inadequate primary immunization (dominant risk factor worldwide)
  • Waning immunity in adults (especially those >65 years) - the primary driver in high-income countries
  • Intravenous drug use - accounts for ~50% of US cases
  • Diabetes mellitus
  • Immunosuppression
Wound types (portals of entry, in approximate order of frequency):
CategoryExamples
Traumatic woundsPuncture wounds, lacerations, abrasions, crush injuries
Tetanus-prone wound featuresDepth ≥1 cm, >6 hours old, bite injuries, stellate/avulsion wounds, burns, frostbite
Drug-relatedIV injection sites, skin-popping
ObstetricChildbirth, abortion, umbilical cord (neonates)
SurgicalIntestinal operations, abdominal/pelvic procedures
MiscellaneousChronic ulcers, otitis media, dental procedures, corneal abrasions, foreign bodies
A history of identifiable injury is present in >70% of cases, but the wound may be trivial. A minority have no apparent source (endogenous colonic carriage is the suspected origin in such cases).
  • Rosen's Emergency Medicine, p. 2588; Campbell's Operative Orthopaedics, p. 3306-3307

Age Distribution

SettingMost Affected Age Group
Low/middle-income countriesNeonates (tetanus neonatorum)
USA/high-income countriesAdults >65 years (0.23 cases/million - highest incidence in the US) + injection drug users
General unvaccinated/under-vaccinatedAny age
As childhood immunization programs improve in high-income countries, the age distribution shifts to older adults - a direct consequence of vaccine success in children but incomplete booster uptake in adults.
  • Rosen's Emergency Medicine, p. 2586

Case Fatality Rates

PopulationCFR
Overall (USA, 2009-2017)7%
Overall (USA, Rosen's data)~18%
Patients >70 yearsApproaches 50%
Obstetric/puerperal tetanusOften >50%
Neonatal tetanus (low-resource settings)Very high without ICU
Fully vaccinated patientsCases reported; no deaths
The leading causes of death are respiratory failure (laryngospasm, ventilatory muscle rigidity) and autonomic instability (labile blood pressure, arrhythmias, hyperthermia).

Impact of Vaccination - Key Epidemiologic Points

  • Tetanus toxoid is one of the most effective vaccines ever developed
  • Global DTP3 coverage rose from <25% (1980) to >88% (2018) - directly mirroring case decline
  • Immunity is NOT lifelong: booster doses (Td) are needed every 10 years; poor adult compliance is the main driver of residual cases in high-income settings
  • Maternal and neonatal tetanus (MNT) elimination (goal: <1 case/1,000 live births per district) has been achieved in many countries through targeted maternal immunization campaigns
  • Tetanus can never be eradicated due to the environmental spore reservoir - surveillance and vaccination must be permanent
Key sources:
  • Goldman-Cecil Medicine (International Edition), p. 1330-1340
  • Rosen's Emergency Medicine: Concepts and Clinical Practice, p. 2589-2590
  • Creasy & Resnik's Maternal-Fetal Medicine, p. 4112-4136
  • Campbell's Operative Orthopaedics 15th Ed 2026, p. 3276-3307
  • WHO Immunization Data Portal
  • The Lancet (2025) - Tetanus review
This is a shared conversation. Sign in to Orris to start your own chat.